Foley Partner John Wilson was quoted in an article that appeared in Agenda on October 11, 2010 titled “No Proxy Access in 2011 as SEC Approves Stay.” Wilson discusses the SEC order agreeing to delay the implementation of proxy access until the D.C. circuit court rules on a lawsuit seeking to overturn the regulation. He states that the order makes sense given the legal implications of moving forward with proxy access only to have it invalidated by the court, but notes that the SEC would likely appeal the decision were the circuit court to overturn the regulation. Wilson adds that companies should be proactive with their shareholders in the event that the SEC moves forward with a modified version of its proxy access rules.
People
Related News
May 1, 2026
In the News
David Rosen Weighs in on SCOTUS Review of Skinny Label Patent Dispute
Foley & Lardner LLP partner David Rosen is featured across the media for his perspective on the U.S. Supreme Court case Hikma Pharmaceuticals v. Amarin Pharma.
April 27, 2026
In the News
Jesse Neil Featured as a Distinguished Leader in Law.com's Southeastern Legal Awards
Foley & Lardner LLP partner Jesse Neil is recognized in Law.com as one of the Distinguished Leader honorees for the 2026 Southeastern Legal Awards.
April 27, 2026
In the News
David Rosen and William Holtz Analyze FDA Approval Speed, Biotech Pressures
Foley & Lardner LLP attorneys David Rosen and William Holtz are quoted in the PharmaVoice article, “FDA’s need for speed could strain small biotechs. Here’s how they can keep up,” examining the FDA’s accelerated drug approval initiatives and its impact on smaller pharmaceutical companies.